Long-term Co-administration Study of OPC-262 in Patients With Type 2 Diabetes Mellitus.
Phase of Trial: Phase III
Latest Information Update: 07 Feb 2017
At a glance
- Drugs Saxagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Otsuka Pharmaceutical
- 03 Oct 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 08 Sep 2010 New trial record
- 07 Sep 2010 Planned number of patients changed from 450 to 450.